Drug Shortage Report for PERGOVERIS
Report ID | 174191 |
Drug Identification Number | 02470667 |
Brand name | PERGOVERIS |
Common or Proper name | follitropin alfa/lutropin alfa |
Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Market Status | MARKETED |
Active Ingredient(s) | LUTROPIN ALFA FOLLITROPIN ALFA |
Strength(s) | 450UNIT 900UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 pen |
ATC code | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-11-10 |
Estimated end date | 2022-11-18 |
Actual end date | 2022-11-17 |
Shortage status | Resolved |
Updated date | 2022-11-18 |
Company comments | Unexpected demand increase due to drug shortage of products by other manufacturer(s) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-11-18 | English | Compare |
v5 | 2022-11-17 | French | Compare |
v4 | 2022-11-17 | English | Compare |
v3 | 2022-11-11 | English | Compare |
v2 | 2022-11-10 | French | Compare |
v1 | 2022-11-10 | English | Compare |
Showing 1 to 6 of 6